Zealthy has introduced an upgraded virtual weight-loss care platform that integrates telehealth services, insurance coordination, prescription management, and patient support. The platform allows eligible patients to complete an online health assessment, connect with licensed providers, and receive prescriptions like Zepbound, an FDA-approved injectable medication for weight loss and sleep apnea. The program offers a membership starting at $39 for the first month and $135 thereafter, with insurance coordination to help reduce medication costs. This service aims to simplify access to obesity treatment with ongoing medical and coaching support, though costs and insurance coverage vary by individual.
EARNED, a baseball culture brand, has signed Cody Boshell, a leading 2026 MLB Draft prospect and University of Tennessee commit, as a brand ambassador. Boshell is recognized for his powerful left-handed batting and strong work ethic, aligning with EA...
Daiwa downgraded JD.com stock to Hold with a $27 price target, citing limited upside after recent 9.67% share decline. Despite this, analysts expect JD.com to report strong earnings and revenue growth, with EPS projected to rise 21.74% and revenue by...
ASE Technology Holding Co Ltd reported strong growth driven by demand for AI chip packaging, with gross margins rising to 20.1% from 16.8% year-over-year. The company expects its advanced packaging revenue to exceed $3.5 billion in 2026, reflecting r...
More than 20 pharmaceutical companies are actively researching and developing over 25 drugs for acute kidney injury (AKI), a condition causing sudden kidney function decline. Key players like AstraZeneca and Akebia Therapeutics are advancing therapie...
Halper Sadeh LLC is investigating whether shareholders of Dana Incorporated, Roku, TruBridge, and Affinity Bancshares are receiving fair treatment in their companies' proposed sales. The firm highlights potential conflicts where insiders might gain b...
